|
US3539380A
(en)
|
1968-01-08 |
1970-11-10 |
Upjohn Co |
Methylcellulose and polyalkylene glycol coating of solid medicinal dosage forms
|
|
GB1530201A
(en)
|
1976-04-14 |
1978-10-25 |
Pfizer Ltd |
Process for the preparation of aminoglycoside antibiotics and intermediates therefor
|
|
GB1566609A
(en)
|
1977-03-10 |
1980-05-08 |
Reckitt & Colmann Prod Ltd |
Pharmaceutical compositions containing cholestyramine and alginic acid
|
|
DE3066728D1
(en)
|
1979-04-30 |
1984-03-29 |
Max Planck Gesellschaft |
Tyrosine derivatives, process for their production and their use in the synthesis of peptides
|
|
US4900757A
(en)
|
1988-12-08 |
1990-02-13 |
Merrell Dow Pharmaceuticals Inc. |
Hypocholesterolemic and antiatherosclerotic uses of bix(3,5-di-tertiary-butyl-4-hydroxyphenylthio)methane
|
|
DE3930168A1
(de)
|
1989-09-09 |
1991-03-14 |
Knoll Ag |
Verbesserte verabreichungsform fuer colestyramin
|
|
IL95574A
(en)
|
1989-09-09 |
1994-11-11 |
Knoll Ag |
Colestyramine preparation
|
|
DE59108326D1
(de)
|
1990-12-06 |
1996-12-12 |
Hoechst Ag |
Gallensäurederivate, Verfahren zu ihrer Herstellung und Verwendung dieser Verbindung als Arzneimittel
|
|
AU653658B2
(en)
|
1991-12-20 |
1994-10-06 |
Hoechst Aktiengesellschaft |
Polymers and oligomers of bile acid derivatives, process for their preparation and their use as pharmaceuticals
|
|
JPH05186357A
(ja)
|
1991-12-31 |
1993-07-27 |
Shigeo Ochi |
飲食物消化分解産物吸収抑制手段
|
|
GB9203347D0
(en)
|
1992-02-17 |
1992-04-01 |
Wellcome Found |
Hypolipidaemic compounds
|
|
IT1257793B
(it)
|
1992-05-18 |
1996-02-13 |
|
Composizione farmaceutica a base di acidi biliari in microgranuli a rilascio controllato
|
|
ES2111092T3
(es)
|
1992-06-12 |
1998-03-01 |
Hoechst Ag |
Derivados de acidos biliares, procedimiento para su preparacion y utilizacion de estos compuestos como medicamentos.
|
|
US5350584A
(en)
|
1992-06-26 |
1994-09-27 |
Merck & Co., Inc. |
Spheronization process using charged resins
|
|
IL108634A0
(en)
|
1993-02-15 |
1994-05-30 |
Wellcome Found |
Hypolipidaemic heterocyclic compounds, their prepatation and pharmaceutical compositions containing them
|
|
ZA941003B
(en)
|
1993-02-15 |
1995-08-14 |
Wellcome Found |
Hypolipidaemic compounds
|
|
PT621032E
(pt)
|
1993-04-23 |
2001-01-31 |
Novartis Ag |
Dispositivo de distribuicao de libertacao controlada de farmaco
|
|
TW289757B
(cg-RX-API-DMAC7.html)
|
1993-05-08 |
1996-11-01 |
Hoechst Ag |
|
|
EP0624593A3
(de)
|
1993-05-08 |
1995-06-07 |
Hoechst Ag |
Gallensäurederivate, Verfahren zu ihrer Herstellung und Verwendung dieser Verbindungen als Arzneimittel.
|
|
TW289021B
(cg-RX-API-DMAC7.html)
|
1993-05-08 |
1996-10-21 |
Hoechst Ag |
|
|
TW289020B
(cg-RX-API-DMAC7.html)
|
1993-05-08 |
1996-10-21 |
Hoechst Sktiengesellschaft |
|
|
ZA956647B
(en)
|
1994-08-10 |
1997-02-10 |
Wellcome Found |
Hypolipidaemic compounds.
|
|
US6642268B2
(en)
|
1994-09-13 |
2003-11-04 |
G.D. Searle & Co. |
Combination therapy employing ileal bile acid transport inhibiting benzothipines and HMG Co-A reductase inhibitors
|
|
US5994391A
(en)
|
1994-09-13 |
1999-11-30 |
G.D. Searle And Company |
Benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
|
AU700557B2
(en)
|
1994-09-13 |
1999-01-07 |
Monsanto Company |
Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
|
US6262277B1
(en)
|
1994-09-13 |
2001-07-17 |
G.D. Searle And Company |
Intermediates and processes for the preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
|
GB9423172D0
(en)
|
1994-11-17 |
1995-01-04 |
Wellcom Foundation The Limited |
Hypolipidemic benzothiazepines
|
|
US5811388A
(en)
|
1995-06-07 |
1998-09-22 |
Cibus Pharmaceutical, Inc. |
Delivery of drugs to the lower GI tract
|
|
AU724620B2
(en)
|
1996-01-16 |
2000-09-28 |
Sokol, Ronald J Dr. |
Use of antioxidant agents to treat cholestatic liver disease
|
|
HUP9903047A3
(en)
|
1996-03-11 |
2002-12-28 |
G D Searle & Co Chicago |
Novel benzothiazepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake
|
|
EP0912861B1
(de)
|
1996-07-24 |
2000-11-29 |
Zumtobel Staff GmbH |
Adapter für ein haltemittel, welches zum befestigen einer einbauleuchte in einer einbauöffnung bestimmt ist, oder haltemittel oder einbauleuchte mit einem solchen adapter
|
|
DE19633268A1
(de)
|
1996-08-19 |
1998-02-26 |
Hoechst Ag |
Polymere Gallensäure-Resorptionsinhibitoren mit gleichzeitiger Gallensäure-Adsorberwirkung
|
|
GB9704208D0
(en)
|
1997-02-28 |
1997-04-16 |
Glaxo Group Ltd |
Chemical compounds
|
|
SK125099A3
(en)
|
1997-03-11 |
2001-02-12 |
Searle & Co |
Combination of ileal bile acid transport inhibiting benzothiepines and hmg co-a reductase inhibitors
|
|
EP0864582B1
(en)
|
1997-03-14 |
2003-06-04 |
Aventis Pharma Deutschland GmbH |
Hypolipidemic 1,4-benzothiazepine-1,-dioxides
|
|
US6635280B2
(en)
|
1997-06-06 |
2003-10-21 |
Depomed, Inc. |
Extending the duration of drug release within the stomach during the fed mode
|
|
AUPO763197A0
(en)
|
1997-06-30 |
1997-07-24 |
Sigma Pharmaceuticals Pty Ltd |
Health supplement
|
|
ES2195428T3
(es)
|
1997-12-19 |
2003-12-01 |
Searle & Co |
Metodo para preparar oxidos de tetrahidrobenzotiepina enriquecidos enantiometricamente.
|
|
GB9800428D0
(en)
|
1998-01-10 |
1998-03-04 |
Glaxo Group Ltd |
Chemical compounds
|
|
JP2002513013A
(ja)
|
1998-04-24 |
2002-05-08 |
藤沢薬品工業株式会社 |
グアニジン誘導体
|
|
DE19825804C2
(de)
|
1998-06-10 |
2000-08-24 |
Aventis Pharma Gmbh |
1,4-Benzothiepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
|
|
US6221897B1
(en)
|
1998-06-10 |
2001-04-24 |
Aventis Pharma Deutschland Gmbh |
Benzothiepine 1,1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use
|
|
AU5194999A
(en)
|
1998-08-07 |
2000-02-28 |
Takeda Chemical Industries Ltd. |
Benzothiepin derivatives, process for the preparation of the same and uses thereof
|
|
ES2200587T3
(es)
|
1998-12-23 |
2004-03-01 |
G.D. Searle Llc |
Combinaciones de inhibidors del transporte de acidos biliares del ileon e inhibidores de la proteina de transferencia de colesteril ester para indicaciones cardiovasculares.
|
|
CZ20012344A3
(cs)
|
1998-12-23 |
2002-01-16 |
G. D. Searle Llc |
Kombinace pro kardiovaskulární indikace
|
|
DK1140189T3
(da)
|
1998-12-23 |
2003-09-15 |
Searle Llc |
Kombinationer af ileal galdesyre-transportinhibitorer og fibrinsyrederivater til cardiovaskulære indikationer
|
|
BR9916567A
(pt)
|
1998-12-23 |
2001-12-11 |
Searle Llc |
Combinações de inibidores do transporte ácido dabile ileal e derivados do ácido nicotìnico paraindicações cardiovasculares
|
|
MXPA01006470A
(es)
|
1998-12-23 |
2003-06-06 |
Searle Llc |
Combinaciones de inhibidores de transporte de acido biliar ileal y agentes de secuentro de acido biliar para indicaciones cardiovasculares.
|
|
CA2362147A1
(en)
|
1999-02-12 |
2000-08-17 |
Steve A. Kolodziej |
1,2-benzothiazepines for the treatment of hyperlipidemic diseases
|
|
DE19916108C1
(de)
|
1999-04-09 |
2001-01-11 |
Aventis Pharma Gmbh |
Mit Zuckerresten substituierte 1,4-Benzothiazepin-1,1-dioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
|
|
SE9901387D0
(sv)
|
1999-04-19 |
1999-04-19 |
Astra Ab |
New pharmaceutical foromaulations
|
|
US6287609B1
(en)
|
1999-06-09 |
2001-09-11 |
Wisconsin Alumni Research Foundation |
Unfermented gel fraction from psyllium seed husks
|
|
AU784722B2
(en)
|
2000-02-18 |
2006-06-01 |
Merck & Co., Inc. |
Aryloxyacetic acids for diabetes and lipid disorders
|
|
SE0000772D0
(sv)
|
2000-03-08 |
2000-03-08 |
Astrazeneca Ab |
Chemical compounds
|
|
US20020061888A1
(en)
|
2000-03-10 |
2002-05-23 |
Keller Bradley T. |
Combination therapy for the prophylaxis and treatment of hyperlipidemic conditions and disorders
|
|
US6586434B2
(en)
|
2000-03-10 |
2003-07-01 |
G.D. Searle, Llc |
Method for the preparation of tetrahydrobenzothiepines
|
|
TWI241195B
(en)
|
2000-04-10 |
2005-10-11 |
Shionogi & Co |
Preventive agent for bile acidic diarrhea
|
|
US20020183307A1
(en)
|
2000-07-26 |
2002-12-05 |
Tremont Samuel J. |
Novel 1,4-benzothiazephine and 1,5-benzothiazepine compounds as inhibitors of apical sodium co-dependent bile acid transport and taurocholate uptake
|
|
JP4265911B2
(ja)
|
2000-07-28 |
2009-05-20 |
エフ.ホフマン−ラ ロシュ アーゲー |
新規医薬組成物
|
|
FR2812886B1
(fr)
|
2000-08-08 |
2002-11-08 |
Assist Publ Hopitaux De Paris |
Depistage d'un nouveau syndrome hepatique et ses applications
|
|
SE0003766D0
(sv)
|
2000-10-18 |
2000-10-18 |
Astrazeneca Ab |
Novel formulation
|
|
EG26979A
(en)
|
2000-12-21 |
2015-03-01 |
Astrazeneca Ab |
Chemical compounds
|
|
WO2002053548A1
(fr)
|
2000-12-27 |
2002-07-11 |
Banyu Pharmaceutical Co.,Ltd. |
Derives de la benzothiazepine
|
|
US6506921B1
(en)
|
2001-06-29 |
2003-01-14 |
Virginia Tech Intellectual Properties, Inc. |
Amine compounds and curable compositions derived therefrom
|
|
GB0121337D0
(en)
|
2001-09-04 |
2001-10-24 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0121621D0
(en)
|
2001-09-07 |
2001-10-31 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0121622D0
(en)
|
2001-09-07 |
2001-10-31 |
Astrazeneca Ab |
Chemical compounds
|
|
MY131995A
(en)
|
2001-09-08 |
2007-09-28 |
Astrazeneca Ab |
Benzothiazepine and benzothiadiazepine derivatives with illeal bile acid transport (ibat) inhibitory activity for the treatment hyperlipidaemia
|
|
WO2003022804A2
(en)
|
2001-09-12 |
2003-03-20 |
G.D. Searle Llc |
Method for the preparation of crystalline tetrahydrobenzothiepines
|
|
GB0314079D0
(en)
|
2003-06-18 |
2003-07-23 |
Astrazeneca Ab |
Therapeutic agents
|
|
SE0104334D0
(sv)
|
2001-12-19 |
2001-12-19 |
Astrazeneca Ab |
Therapeutic agents
|
|
GB0229931D0
(en)
|
2002-12-21 |
2003-01-29 |
Astrazeneca Ab |
Therapeutic agents
|
|
WO2003059378A2
(en)
|
2001-12-29 |
2003-07-24 |
Novo Nordisk A/S |
Combined use of a glp-1 compound and another drug for treating dyslipidemia
|
|
GB0201850D0
(en)
|
2002-01-26 |
2002-03-13 |
Astrazeneca Ab |
Therapeutic treatment
|
|
GB0209467D0
(en)
|
2002-04-25 |
2002-06-05 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0213669D0
(en)
|
2002-06-14 |
2002-07-24 |
Astrazeneca Ab |
Chemical compounds
|
|
GB0216321D0
(en)
|
2002-07-13 |
2002-08-21 |
Astrazeneca Ab |
Therapeutic treatment
|
|
US7312208B2
(en)
|
2002-08-28 |
2007-12-25 |
Asahi Kasei Pharma Corporation |
Quaternary ammonium compounds
|
|
WO2004020421A1
(ja)
|
2002-08-28 |
2004-03-11 |
Asahi Kasei Pharma Corporation |
新規な4級アンモニウム化合物
|
|
GB0304194D0
(en)
|
2003-02-25 |
2003-03-26 |
Astrazeneca Ab |
Chemical compounds
|
|
WO2004108067A2
(en)
|
2003-04-03 |
2004-12-16 |
Sun Pharmaceutical Industries Limited |
Programmed drug delivery system
|
|
GB0307918D0
(en)
|
2003-04-05 |
2003-05-14 |
Astrazeneca Ab |
Therapeutic use
|
|
JP4711953B2
(ja)
|
2004-02-27 |
2011-06-29 |
旭化成ファーマ株式会社 |
新規なベンゾチアゼピン及びベンゾチエピン化合物
|
|
WO2005082414A2
(en)
|
2004-03-02 |
2005-09-09 |
Astellas Pharma Inc. |
Concomitant drugs of a sulfonamide and another therapeutic agent
|
|
EP1593671A1
(en)
|
2004-03-05 |
2005-11-09 |
Graffinity Pharmaceuticals AG |
DPP-IV inhibitors
|
|
TWI354569B
(en)
|
2004-05-28 |
2011-12-21 |
Bristol Myers Squibb Co |
Coated tablet formulation and method
|
|
JP4896480B2
(ja)
|
2004-10-01 |
2012-03-14 |
第一三共ヘルスケア株式会社 |
陰イオン交換樹脂の粒子状組成物
|
|
WO2006121861A2
(en)
|
2005-05-05 |
2006-11-16 |
Microbia, Inc. |
Biphenylazetidinone cholesterol absorption inhibitors
|
|
DE102005033099A1
(de)
|
2005-07-15 |
2007-01-18 |
Sanofi-Aventis Deutschland Gmbh |
Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, Verfahren zu dessen Herstellung, diese Verbindung enthaltende Arzneimittel und dessen Verwendung
|
|
DE102005033100B3
(de)
|
2005-07-15 |
2007-01-25 |
Sanofi-Aventis Deutschland Gmbh |
Neues 1,4-Benzothiazepin-1,1-Dioxidderivat mit verbesserten Eigenschaften, diese Verbindung enthaltene Arzneimittel und Verfahren zu deren Herstellung
|
|
BRPI0616195A2
(pt)
|
2005-09-20 |
2011-06-14 |
Novartis Ag |
uso de um inibidor de dpp-iv para reduzir eventos hipoglicÊmicos
|
|
US20100286122A1
(en)
|
2006-04-10 |
2010-11-11 |
Kevin Belyk |
CGRP Antagonist Salt
|
|
GB0607534D0
(en)
|
2006-04-13 |
2006-05-24 |
Univ London Pharmacy |
Colonic drug delivery formulation
|
|
WO2008058631A1
(de)
|
2006-11-14 |
2008-05-22 |
Sanofi-Aventis Deutschland Gmbh |
Neue 1,4-benzothiepin-1,1-dioxidderivate mit verbesserten eigenschaften, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
DE102006053637B4
(de)
|
2006-11-14 |
2011-06-30 |
Sanofi-Aventis Deutschland GmbH, 65929 |
Neue mit Fluor substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
|
DE102006053635B4
(de)
|
2006-11-14 |
2011-06-30 |
Sanofi-Aventis Deutschland GmbH, 65929 |
Neue mit Benzylresten substituierte 1,4-Benzothiepin-1,1-Dioxidderivate, diese Verbindungen enthaltende Arzneimittel und deren Verwendung
|
|
PL2200588T3
(pl)
|
2007-09-25 |
2019-09-30 |
Solubest Ltd. |
Kompozycje zawierające lipofilowe związki aktywne i sposób ich wytwarzania
|
|
KR20110059750A
(ko)
|
2008-09-02 |
2011-06-03 |
유에스브이 리미티드 |
가교 폴리머
|
|
US9339480B2
(en)
|
2008-11-26 |
2016-05-17 |
Satiogen Pharmaceuticals, Inc. |
Bile acid recycling inhibitors for treatment of obesity and diabetes
|
|
JO3131B1
(ar)
|
2010-04-27 |
2017-09-20 |
Glaxosmithkline Llc |
مركبات كيميائية
|
|
ES2552657T3
(es)
|
2010-05-26 |
2015-12-01 |
Satiogen Pharmaceuticals, Inc. |
Inhibidores del reciclado de ácidos biliares y saciógenos para el tratamiento de diabetes, obesidad, y afecciones gastrointestinales inflamatorias
|
|
LT3023102T
(lt)
|
2010-11-04 |
2018-09-25 |
Albireo Ab |
Ibat inhibitoriai, skirti kepenų ligų gydymui
|
|
MY176863A
(en)
|
2010-11-08 |
2020-08-24 |
Albireo Ab |
Ibat inhibitors for treatment of metabolic disorders and related conditions
|
|
US20120114588A1
(en)
|
2010-11-08 |
2012-05-10 |
Albireo Ab |
Ibat inhibitors for treatment of metabolic disorders and related conditions
|
|
CA2815698C
(en)
|
2010-11-08 |
2019-04-30 |
Albireo Ab |
A pharmaceutical combination comprising an ibat inhibitor and a bile acid binder
|
|
EA201891154A1
(ru)
|
2011-10-28 |
2019-02-28 |
ЛУМЕНА ФАРМАСЬЮТИКАЛС ЭлЭлСи |
Ингибиторы рециклинга желчных кислот при лечении холестатических заболеваний печени у детей
|
|
EA038594B1
(ru)
|
2011-10-28 |
2021-09-21 |
Шайр Хьюман Дженетик Терапис, Инк. |
Ингибиторы рециркуляции желчных кислот для лечения гиперхолемии и холестатического заболевания печени
|
|
JO3301B1
(ar)
|
2013-04-26 |
2018-09-16 |
Albireo Ab |
تعديلات بلورية على إيلوبيكسيبات
|
|
WO2015193788A1
(en)
|
2014-06-16 |
2015-12-23 |
Valpharma International S.P.A. |
Formulation for oral administration containing mesalazine
|
|
CA2952405A1
(en)
|
2014-06-25 |
2015-12-30 |
Ea Pharma Co., Ltd. |
Solid formulation and method for stabilizing the same
|
|
KR20220082931A
(ko)
|
2014-06-25 |
2022-06-17 |
이에이 파마 가부시키가이샤 |
고형 제제 및 그의 착색 방지 또는 착색 감소 방법
|
|
US9684018B2
(en)
|
2014-11-19 |
2017-06-20 |
Texas Instruments Incorporated |
Current sense circuit that operates over a wide range of currents
|
|
US10441605B2
(en)
|
2016-02-09 |
2019-10-15 |
Albireo Ab |
Oral cholestyramine formulation and use thereof
|
|
US10441604B2
(en)
|
2016-02-09 |
2019-10-15 |
Albireo Ab |
Cholestyramine pellets and methods for preparation thereof
|
|
US10786529B2
(en)
|
2016-02-09 |
2020-09-29 |
Albireo Ab |
Oral cholestyramine formulation and use thereof
|